Disparities in the Use of Prophylactic Treatments in Reproductive Health Between the Sexes: A Recommendation for the Use of HPV Vaccination Schemes Rather than Surgical Interventions to Reduce Inequities and Threats to the Public's Health
On the issue of prophylactic treatment of reproductive diseases, the sexes have historically been treated differently under medical ethics guidelines and the laws of the United States. Women have drawn the focus of medical and legal scrutiny on issues of prophylactic reproductive health. Women were often required to undergo quarantine and forced to recieve treatment for reproductive diseases considered dangerous to public health. Women are now afforded protections against involuntary prophylactic procedures to prevent diseases in reproductive organs. Specifically, women are provided access to vaccinations against the human papillomavirus at a higher rate than males despite the disease's ability to negatively impact both sexes. In order to control the spread of the human papillomavirus and to best ensure an opportunity for both sexes to maintain positive reproductive health, the rules guiding medical professionals and the laws of the United States must treat both sexes equally with regard to granting protections from unnecessary prophylactic treatments and in allowing access to human papillomavirus vaccinations.
Paul J. McLaughlin, 14 Fla. A&M U. L. Rev. 1 (2019).